Intuitive Surgical (NASDAQ:ISRG) Trading Up 0.1% – Here’s What Happened

Intuitive Surgical, Inc. (NASDAQ:ISRG) was up 0.1% during trading on Monday . The stock traded as high as $600.58 and last traded at $592.31. Approximately 306,843 shares were traded during mid-day trading, a decline of 82% from the average daily volume of 1,682,286 shares. The stock had previously closed at $591.79.

Analyst Ratings Changes

A number of analysts recently commented on ISRG shares. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Jefferies Financial Group upped their price target on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Citigroup raised their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Wells Fargo & Company boosted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Finally, Stifel Nicolaus raised their price target on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Stock Down 0.0 %

The company has a market cap of $210.73 billion, a price-to-earnings ratio of 92.62, a PEG ratio of 5.85 and a beta of 1.39. The stock has a 50 day simple moving average of $565.45 and a 200 day simple moving average of $525.60.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now directly owns 353 shares in the company, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,348 shares of company stock worth $3,587,582 in the last 90 days. 0.90% of the stock is owned by company insiders.

Institutional Trading of Intuitive Surgical

A number of hedge funds and other institutional investors have recently made changes to their positions in ISRG. Atala Financial Inc acquired a new position in Intuitive Surgical during the 4th quarter worth $25,000. Hurley Capital LLC bought a new stake in Intuitive Surgical in the fourth quarter valued at about $28,000. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical during the fourth quarter valued at approximately $26,000. Parvin Asset Management LLC acquired a new stake in Intuitive Surgical during the fourth quarter valued at approximately $26,000. Finally, BankPlus Trust Department acquired a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $28,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.